HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Baldas, V. Articles by Ventura, A. Search for Related Content PubMed PubMed Citation Articles by Baldas, V. Articles by Ventura, A. Related Collections Clinical Immunology

Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease

¹ Department of Reproductive and Development Science and Service of Dentistry, I.R.C.C.S. "Burlo Garofolo", and
² Department of Biology, University of Trieste, Trieste, Italy;

^aaddress correspondence to this author at: Clinica Pediatrica, Istituto per l’Infanzia "Burlo Garofolo", Via dell’Istria 65/1, IT-34100 Trieste, Italy; fax 39-040-3785-210, e-mail not@burlo.trieste.it

The first 300 words of the full text of this article appear below.

Undetected celiac disease (CD) can cause serious complications and excessive mortality (1)(2)(3). Noninvasive tests could be useful in physicians’ offices to identify patients for intestinal biopsies (4). Serum IgA anti-endomysium (AEA) and anti-human transglutaminase (anti-htTG) antibody assays are the most widely used laboratory tests for CD (5). Autoantibody determinations have been simplified by the use of rapid testing (6)(7), but when saliva specimens were evaluated for AEA testing, they were found to be not suitable (8).

To evaluate the potential utility of saliva as a sample for anti-htTG testing, we compared salivary IgA anti-htTG (measured by ELISA with a dot-blot method and an AEA test) with serum IgA anti-htTG antibodies (measured by ELISA and an AEA test) in patients with CD and in controls. Salivary IgA anti-htTG activity was analyzed for the IgA secretory chain by use of a monoclonal antibody. The recognition patterns of the saliva samples were compared with those for the serum samples and with the pattern for a gut-derived IgA monoclonal antibody to htTG from one CD patient, using two transglutaminase deletion mutants, one recognized and one not by the patients’ sera (9).

We studied 47 untreated CD patients (29 females and 18 males; median age, 19 years; range, 2–52 years) diagnosed in 2002–2003 according to ESPGHAN criteria (10) and 47 patients with celiac disease (26 females and 21 males; median age, 19 years; range, 4–50 years) on a gluten-free diet (GFD) for at least 12 months. We recruited 51 healthy controls with no history of gastrointestinal or autoimmune diseases (25 females and 26 males; median age, 14 years; range, 6–50 years) and identified samples from 49 individuals suffering from various gastrointestinal diseases (18 with Crohn . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				L. Pastore, G. Campisi, D. Compilato, and L. L. Muzio Orally Based Diagnosis of Celiac Disease: Current Perspectives Journal of Dental Research, December 1, 2008; 87(12): 1100 - 1107. [Abstract] [Full Text] [PDF]